Cancer ImmunotherapyCancer Drug Resistance

Hemorrhage-activated NRF2 in tumor-associated macrophages drives cancer growth, invasion, and immunotherapy resistance

Journal of Clinical Investigation

Abstract

Microscopic hemorrhage is a common aspect of cancers. Using spatial transcriptomics, we found that NRF2-activated myeloid cells possessing characteristics of procancerous TAMs cluster in perinecrotic hemorrhagic tumor regions. We identified heme as a pivotal microenvironmental factor steering macrophages toward protumorigenic activities.

Key Findings

  • Intratumoral hemorrhage drives cancer-promoting TAMs via NRF2 activation
  • Heme from red blood cell breakdown activates NRF2 in macrophages
  • NRF2-activated TAMs are resistant to reprogramming by IFN-γ and anti-CD40
  • Spatial transcriptomics revealed NRF2-TAMs cluster in hemorrhagic regions

Clinical Significance

First study identifying hemorrhage-driven NRF2 activation as a driver of immunotherapy resistance through TAM reprogramming.

Citation

Schaer, D.J. et al. (2024). Hemorrhage-activated NRF2 in TAMs. Journal of Clinical Investigation.

DOI: 10.1172/JCI174528